Anticancer activity of the iron facilitator LS081

BACKGROUND: Cancer cells have increased levels of transferrin receptor and lower levels of ferritin, an iron deficient phenotype that has led to the use of iron chelators to further deplete cells of iron and limit cancer cell growth. As cancer cells also have increased reactive oxygen species (ROS)...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhen, Tanaka, Hiroki, Galiano, Floyd, Glass, Jonathan
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3077325/
https://www.ncbi.nlm.nih.gov/pubmed/21453502
http://dx.doi.org/10.1186/1756-9966-30-34

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3077325/
https://www.ncbi.nlm.nih.gov/pubmed/21453502
http://dx.doi.org/10.1186/1756-9966-30-34

Ejemplares similares